Male breast malignancy in Jos University Teaching Hospital

Kidmas, AT; Ugwu, B T; Manasseh, A N; Iya, D; Opaluwa, AS

doi:10.4314/wajm.v24i1.28160

Cited by 27 publications

(22 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although most texts put the male incidence at 1% of breast cancers 7 the proportion in various countries is variable. Analysis of pathology specimen in Ghana puts the incidence at 2% 8 and in Jos (Nigeria) it has been reported as high as 8.6% 9 . In this series it is 1.3%.…”

Section: Discussionmentioning

confidence: 99%

A study of breast cancer in korle bu teaching hospital: assessing the impact of health education

Clegg-Lamptey

Hodasi²

2010

Ghana Medical Journal

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

A study of breast cancer in korle bu teaching hospital: assessing the impact of health education

Clegg-Lamptey

Hodasi²

2010

Ghana Medical Journal

View full text Add to dashboard Cite

“…In our study the risk factors found were gynaecomastia (13.6%), breast trauma (4.6%), jaundice (4.6%), and obesity (4.6%). The clinical feature is dominated by the skin ulcero-hemorrhagic lesion (63.6%), this sign is accounted for 52–73.1% in African studies [3, 11–13]. …”

Section: Discussionmentioning

confidence: 99%

Male breast cancer: 22 case reports at the National Hospital of Niamey- Niger (West Africa)

Sani¹,

Yacouba²,

Hassane³

2010

Pan Afr Med Jrnl

View full text Add to dashboard Cite

Background: Male breast cancer (MBC) is rare. The objective of the study is to report clinicopathological characteristics, treatment patterns, and outcomes of MBC. Method: This study, which includes two parts (retrospective and prospective), focused on all hospitalized male patients with breast cancer during 17 years (1992)(1993)(1994)(1995)(1996)(1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008) with histological confirmation. Results: The series included 22 patients. The mean age was 52.8 years (range: 28-80 years). MBC represented 5.7% of all breast cancers. Most patients had an advanced disease with skin ulceration and inflammation T3 (31.9%) and T4 (59.1%). The majority of patients came from rural areas (63.6%). The duration of signs ranged from 1 to 7 years. Histology found infiltrating ductal carcinoma in 14 cases (63.6%), sarcoma in 3 cases (13.6%), papillary carcinoma in 2 cases (9%), and lobular carcinoma, medullar carcinoma, and mucinous carcinoma in 4.6% each of the others cases. The treatment had consisted of a radical mastectomy (Halsted or Patey) in 19 cases (86.4%) with axillary clearance and incomplete resection in 3 cases (13.6%). In the retrospective study follow-up of 14 patients, we lost sight of 13 patients 6 months after surgery. In the prospective study of 8 patients 10 to 36 months after mastectomy, 4 patients were deceased (50%), 4 were alive with 1 case having a local recurrence and pulmonary metastasis. Conclusion: The advanced clinical forms of MBC are most frequent with skin ulceration and nodal enlargement. The absence of radiotherapy and the low access of chemotherapy limited the treatment to radical mastectomy (Halsted) in the majority of cases.

show abstract

“…The incidence is 0.8-1.5 cases per 100 000 male population, accounting for 1% of all breast cancer diagnoses (Office of National Statistics 2002; Hodgson et al 2004). The highest incidence occurs in men aged over 70 years (Kidmas et al 2005). In families with hereditary breast cancer, younger males may be affected.…”

mentioning

confidence: 99%

Ocular presentations of breast cancer

Wickremasinghe

Dansingani

Tranos

et al. 2006

Acta Ophthalmologica Scandinavica

View full text Add to dashboard Cite

IntroductionBreast cancer is the most common malignancy in women (Office of National Statistics 2002). As ophthalmic manifestations are common, the astute ophthalmologist can instigate the search for primary disease when the first presentation is ophthalmic in nature, or, alternatively, play an important role in detecting the metastatic spread of a known primary. Breast cancer accounts for 29% of new malignancies in women in the UK and is a major cause of mortality and morbidity worldwide.The purpose of this article is to provide a review of the ophthalmic manifestations of breast cancer. The subjects covered include the presenting features of metastatic disease involving the visual systems, treatment modalities and strategies currently available, and the ocular effects and complications of treatment. EpidemiologyIncidence rates of breast cancer have increased over the last decade, rising from 90 to 130 per 100 000 population (1988 versus 1998) (Office of National Statistics 2002). In contrast, mortality rates have remained relatively stable since the 1950s. This increase in the incidence of breast cancer is attributed to more effective screening programmes, although a change in the demographics of developed countries and an increasing elderly population may contribute to the growing incidence. Geographical variations exist in breast cancer incidence rates, with higher rates in Europe, North America and Oceania and lower rates in Asia and Africa (Sasco 2001). Doctors practising in the western world should be familiar with the disease.Male breast cancer is rare. The incidence is 0.8-1.5 cases per 100 000 male population, accounting for 1% of all breast cancer diagnoses (Office of National Statistics 2002; Hodgson et al. 2004). The highest incidence occurs in men aged over 70 years (Kidmas et al. 2005). In families with hereditary breast cancer, younger males may be affected. The BRCA2 gene is often implicated in these cases (Lorenzo Bermejo & Hemminki 2005).Ocular manifestations of male breast cancer can occur and this differential diagnosis should not be overlooked (O'Brien et al. 2000;Silvestris et al. 2003;Dieing et al. 2004). Ophthalmic metastases in breast cancerMetastatic disease to the eye from the breast was first described by Johann ABSTRACT.Context: Breast cancer is the most common malignancy in women, with increasing incidence in Europe and North America. The frequency of involvement of the eye and visual pathways is reported to be as high as 30% in patients with known metastatic disease. In some cases, ophthalmic involvement can be the first sign of metastatic spread. Metastasis occurs via the haematogenous route and predominantly involves the choroid. Metastases to other ocular structures, the orbit and the visual pathways have also been described. Paraneoplastic effects are rare but significant. Treatments: Different modalities are employed in the treatment of breast cancer and its metastases. These include chemotherapy and radiotherapy. The ocular adverse effects of these have been well described,...

show abstract

Male breast malignancy in Jos University Teaching Hospital

Cited by 27 publications

References 0 publications

A study of breast cancer in korle bu teaching hospital: assessing the impact of health education

A study of breast cancer in korle bu teaching hospital: assessing the impact of health education

Male breast cancer: 22 case reports at the National Hospital of Niamey- Niger (West Africa)

Ocular presentations of breast cancer

Contact Info

Product

Resources

About